Commentary & Opinion
Editorials Urge FDA to Approve OraSure Technologies' Rapid HIV Test for Home Use
November 3, 2005
An advisory panel of FDA on Thursday is scheduled to review a proposal to make OraSure Technologies' rapid HIV test available for use in the home. After the panel makes a recommendation, OraSure said it likely will formally apply to sell the test over the counter. The test, called the OraQuick Advance Rapid HIV 1/2 Antibody Test, has been proven safe, effective and easy to use and currently is only sold to doctors and clinics. The test requires users to swab their gums and then place the swab in a holder. After 20 minutes, one line appears on the strip if the HIV result is negative, two appear if the result is positive. At-home HIV testing has been debated for the past 18 years, as AIDS advocates and public health officials have feared that making such tests available without counseling might lead people to commit suicide, panic or overwhelm public health clinics (Kaiser Daily HIV/AIDS Report, 10/13). Summaries of two recent editorials on the test appear below.
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.